Technology Platform
QRxPharma's platform technology, a patented fixed-ratio combination of morphine and oxycodone...
Q8003
QRxPharma's lead drug candidate, Q8003 (tradename MOXDUO), is intended for acute moderate to severe pain...
Products & Pipeline
QRxPharma's Dual Opioid portfolio includes three complementary products...
Investors
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) is a commercial-stage specialty pharmaceutical company focused on...